Literature DB >> 24999225

Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.

Shahrukh Hashmi1, Paul Carpenter2, Nandita Khera3, André Tichelli4, Bipin N Savani5.   

Abstract

Because of expanding indications and improvements in supportive care, the utilization of blood and marrow cell transplantation (BMT) to treat various conditions is increasing exponentially, and currently more than 60,000 BMTs are performed annually worldwide. By the year 2030, it is projected that the number of BMT survivors will increase 5-fold, potentially resulting in one half of a million survivors in the United States alone. As the majority of survivors now live beyond the first 2 years after BMT, they are prone to a unique set of complications and late effects. Until recently, BMT experts assumed responsibility for almost all of the care for these survivors, but now oncologists/hematologists, pediatricians, and internists are involved frequently in offering specialized care and preventive services to these survivors. To integrate and translate into clinical practice the unique BMT survivorship issues with current preventive guidelines, a team effort is required. This can be facilitated by a dedicated "long-term-follow-up (LTFU)" clinic that provides lifelong care for BMT survivors. In this review, we first illustrate with clinical vignettes the need for LTFU and then focus upon the following: (1) types of LTFU clinic models, (2) challenges and possible solutions to the establishment of LTFU clinic, and (3) vulnerable transition periods.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Keywords:  Blood and marrow transplantation; Late effects; Survivorship clinic

Mesh:

Year:  2014        PMID: 24999225     DOI: 10.1016/j.bbmt.2014.06.035

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  26 in total

Review 1.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.

Authors:  A Hamblin; D M Greenfield; M Gilleece; N Salooja; M Kenyon; E Morris; N Glover; P Miller; H Braund; A Peniket; B E Shaw; J A Snowden
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

3.  Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.

Authors:  Colleen M Morken; Amye J Tevaarwerk; Amanda K Swiecichowski; James E Haine; Zachary T Williams; Kirsten Norslien; Natalia Arroyo; Xiao Zhang; Bethaney Campbell; Eneida A Mendonca; Mark B Juckett; Mary E Sesto
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-11       Impact factor: 5.742

4.  The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.

Authors:  G Gifford; N Gilroy; G Dyer; L Brice; M Kabir; M Greenwood; S Larsen; J Moore; D Gottlieb; M Hertzberg; J Kwan; G Huang; J Tan; L Brown; M Hogg; C Ward; I Kerridge
Journal:  Bone Marrow Transplant       Date:  2016-05-23       Impact factor: 5.483

Review 5.  What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

Authors:  C A Clark; M Savani; M Mohty; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-11       Impact factor: 5.483

6.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

Authors:  Minoo Battiwalla; Shahrukh Hashmi; Navneet Majhail; Steven Pavletic; Bipin N Savani; Nonniekaye Shelburne
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-29       Impact factor: 5.742

Review 7.  Patient-centered care coordination in hematopoietic cell transplantation.

Authors:  Nandita Khera; Patricia Martin; Kristen Edsall; Anthony Bonagura; Linda J Burns; Mark Juckett; Olivia King; C Frederick LeMaistre; Navneet S Majhail
Journal:  Blood Adv       Date:  2017-08-22

8.  Long-term follow-up after childhood cancer in France supported by the SFCE-force and weakness-current state, results of a questionnaire and perspectives.

Authors:  Charlotte Demoor-Goldschmidt; Marie-Dominique Tabone; Valérie Bernier; Florent de Vathaire; Claire Berger
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

Review 9.  Sexual health in hematopoietic stem cell transplant recipients.

Authors:  Zhuoyan Li; Prerna Mewawalla; Pamela Stratton; Agnes S M Yong; Bronwen E Shaw; Shahrukh Hashmi; Madan Jagasia; Mohamad Mohty; Navneet S Majhail; Bipin N Savani; Alicia Rovó
Journal:  Cancer       Date:  2015-09-15       Impact factor: 6.860

Review 10.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.